Clinical Trials Directory

Trials / Unknown

UnknownNCT03708783

Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGC

Study on Short and Long-term Outcome of Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
Peking University Cancer Hospital & Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to explore the safety and feasibility of laparoscopic spleen-preserving No. 10 lymph node dissection for patients with advanced middle or upper third gastric cancer.

Detailed description

Radical resection is the primary treatment for patients with advanced middle or upper third gastric cancer. And D2 lymphadenectomy, including No. 10 lymph node dissection, should be performed according to the Japanese treatment guidelines for gastric cancer. Because of the complexity of the anatomy around the spleen, spleen-preserving No. 10 lymph node dissection is difficult. Although Professor Huang from Fujian Medical University Union Hospital has proposed the "Huang's three-step maneuver" to dissect No. 10 lymph node with preserved spleen laparoscopically, such method is far from popularized, especially in North China. In addition, the safety, feasibility and oncological efficacy of this method was not confirmed in such area, either. In this study, a prospective, single center, single-arm, non-inferiority clinical trial will be conducted to evaluate the short and long-term outcome of the laparoscopic spleen-preserving No. 10 lymph node dissection for patients with locally advanced middle or upper third gastric cancer in Beijing.

Conditions

Interventions

TypeNameDescription
PROCEDURElaparoscopic Spleen-Preserving No. 10 Lymph Node DissectionFor patients with locally advanced upper or middle third gastric cancer, laparoscopic total gastrectomy with D2 lymphadenectomy including spleen-preserving No. 10 lymph node dissection is performed.

Timeline

Start date
2018-07-01
Primary completion
2020-12-30
Completion
2023-12-30
First posted
2018-10-17
Last updated
2019-11-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03708783. Inclusion in this directory is not an endorsement.